MME and type 2 diabetes mellitus: Urinary CD10 levels are increased in patients with diabetes and could be used as early biomarkers to predict the incidence or progression of chronic kidney disease (CKD) at early stages among individuals with type 2 diabetes (Gutta et al., 2018).